Related Experiment Video
Updated: Oct 18, 2025

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
Published on: June 25, 2014
Dietary Bioactive Ingredients Modulating the cAMP Signaling in Diabetes Treatment
Yanan Wang1, Qing Liu2, Seong-Gook Kang3
1Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.
Abstract:
As the prevalence of diabetes increases progressively, research to develop new therapeutic approaches and the search for more bioactive compounds are attracting more attention. Over the past decades, studies have suggested that cyclic adenosine monophosphate (cAMP), the important intracellular second messenger, is a key regulator of metabolism and glucose homeostasis in diverse physiopathological states in multiple organs including the pancreas, liver, gut, skeletal muscle, adipose tissues, brain, and kidney. The multiple characteristics of dietary compounds and their favorable influence on diabetes pathogenesis, as well as their intersections with the cAMP signaling pathway, indicate that these compounds have a beneficial effect on the regulation of glucose homeostasis. In this review, we outline the current understanding of the diverse functions of cAMP in different organs involved in glucose homeostasis and show that a diversity of bioactive ingredients from foods activate or inhibit cAMP signaling, resulting in the improvement of the diabetic pathophysiological process. It aims to highlight the diabetes-preventative or -therapeutic potential of dietary bioactive ingredients targeting cAMP signaling.
Insights
Dietary bioactive compounds can improve diabetes by targeting cyclic adenosine monophosphate (cAMP) signaling. These compounds modulate cAMP in various organs, offering potential for diabetes prevention and treatment.
Area of Science:
- Endocrinology and Metabolism
- Nutritional Science
- Molecular Biology
Background:
- Diabetes prevalence is rising globally, necessitating novel therapeutic strategies.
- Cyclic adenosine monophosphate (cAMP) is a crucial intracellular second messenger regulating metabolism and glucose homeostasis across multiple organs.
- Dietary compounds show promise in managing diabetes, potentially through interactions with the cAMP signaling pathway.
Purpose of the Study:
- To review the role of cAMP in glucose homeostasis across various organs.
- To explore how dietary bioactive ingredients interact with cAMP signaling.
- To highlight the therapeutic potential of these ingredients in diabetes.
Main Methods:
- Literature review of studies on cAMP signaling in glucose metabolism.
- Analysis of research on dietary compounds affecting cAMP pathways.
- Synthesis of information on the impact of these interactions on diabetes pathogenesis.
Main Results:
- cAMP plays diverse roles in glucose regulation in organs like the pancreas, liver, gut, muscle, adipose tissue, brain, and kidney.
- Numerous bioactive food ingredients modulate cAMP signaling pathways.
- Activation or inhibition of cAMP by these ingredients can improve diabetic conditions.
Conclusions:
- Dietary bioactive ingredients targeting cAMP signaling hold significant potential for diabetes management.
- Understanding these interactions can lead to new preventative and therapeutic approaches for diabetes.
- Further research into these compounds could offer novel strategies for improving glucose homeostasis.
Related Concept Videos
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Insulin: The Receptor and Signaling Pathways
cAMP-dependent Protein Kinase Pathways
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Dipeptidyl Peptidase 4 Inhibitors

